Status:
TERMINATED
Neurostimulation to Treat Refractory Angina Pectoris Pain
Lead Sponsor:
MedtronicNeuro
Conditions:
Angina Pectoris
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The therapy under investigation involves an implanted Medtronic neurostimulation system to relieve symptoms of angina pectoris pain. Electrical impulses are applied to targeted areas of the spinal cor...
Eligibility Criteria
Inclusion
- stable angina pectoris associated with reversible myocardial ischemia and significant coronary artery disease (CAD)
- classified as Canadian Cardiovascular Society (CCS) angina class III or IV
- refractory angina despite receiving optimal/maximal medical treatment
- not a candidate for bypass surgery, angioplasty or stent
Exclusion
- not able to perform exercise treadmill testing
- previously received therapeutic transcutaneous electrical nerve stimulation (TENS) (within 2 years) or any spinal cord stimulation (SCS)
- has an implanted pacemaker/defibrillator (ICD)
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
228 Patients enrolled
Trial Details
Trial ID
NCT00200070
Start Date
December 1 2002
End Date
April 1 2007
Last Update
August 30 2010
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Medtronic for Exact Location
Gainesville, Florida, United States
2
Contact Medtronic for Exact Location
Indianapolis, Indiana, United States
3
Contact Medtronic for Exact Location
Boston, Massachusetts, United States
4
Contact Medtronic for Exact Location
Minneapolis, Minnesota, United States